PWM
GILD icon

Perigon Wealth Management’s Gilead Sciences GILD Stock Holding History

Perigon Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.37M Buy
38,551
+487
+1% +$68.2K 0.1% 205
2025
Q4 		$4.67M Sell
38,064
-21
-0.1% -$2.55K 0.08% 221
2025
Q3 		$4.23M Buy
38,085
+1,834
+5% +$208K 0.09% 226
2025
Q2 		$4.02M Sell
36,251
-2,309
-6% -$246K 0.09% 215
2025
Q1 		$4.32M Buy
38,560
+994
+3% +$103K 0.11% 186
2024
Q4 		$3.44M Sell
37,566
-475
-1% -$42.8K 0.08% 218
2024
Q3 		$3.19M Sell
38,041
-1,745
-4% -$133K 0.08% 218
2024
Q2 		$2.73M Sell
39,786
-804
-2% -$53.7K 0.08% 215
2024
Q1 		$2.97M Sell
40,590
-78
-0.2% -$6K 0.09% 200
2023
Q4 		$3.29M Buy
40,668
+3,832
+10% +$298K 0.11% 169
2023
Q3 		$2.76M Buy
36,836
+46
+0.1% +$3.54K 0.11% 169
2023
Q2 		$2.84M Buy
36,790
+1,515
+4% +$121K 0.11% 167
2023
Q1 		$2.93M Buy
35,275
+2,247
+7% +$186K 0.17% 128
2022
Q4 		$2.84M Buy
33,028
+4,131
+14% +$327K 0.18% 130
2022
Q3 		$1.78M Buy
28,897
+1,960
+7% +$124K 0.15% 135
2022
Q2 		$1.67M Buy
26,937
+26
+0.1% +$1.61K 0.14% 144
2022
Q1 		$1.6M Sell
26,911
-23,644
-47% -$1.51M 0.11% 160
2021
Q4 		$3.67M Buy
50,555
+238
+0.5% +$16.4K 0.26% 81
2021
Q3 		$3.52M Buy
50,317
+278
+0.6% +$19.5K 0.31% 75
2021
Q2 		$3.45M Sell
50,039
-5,892
-11% -$393K 0.31% 73
2021
Q1 		$3.62M Sell
55,931
-231
-0.4% -$14.9K 0.37% 60
2020
Q4 		$3.27M Sell
56,162
-3,401
-6% -$205K 0.38% 55
2020
Q3 		$3.76M Buy
59,563
+574
+1% +$39.8K 0.53% 39
2020
Q2 		$4.54M Buy
58,989
+2,341
+4% +$179K 0.72% 30
2020
Q1 		$4.16M Buy
56,648
+6,173
+12% +$427K 0.78% 30
2019
Q4 		$3.31M Buy
50,475
+2,312
+5% +$151K 0.68% 38
2019
Q3 		$3.15M Sell
48,163
-3,172
-6% -$207K 0.74% 35
2019
Q2 		$3.47M Buy
51,335
+165
+0.3% +$10.9K 0.81% 33
2019
Q1 		$3.28M Sell
51,170
-765
-1% -$50.8K 0.76% 34
2018
Q4 		$3.58M Sell
51,935
-3,025
-6% -$211K 0.91% 33
2018
Q3 		$4.24M Buy
54,960
+260
+0.5% +$19.6K 1.05% 22
2018
Q2 		$3.88M Buy
54,700
+4,870
+10% +$344K 1.17% 23
2018
Q1 		$3.76M Sell
49,830
-174
-0.3% -$13.8K 1.38% 17
2017
Q4 		$3.58M Sell
50,004
-625
-1% -$47.5K 1.34% 21
2017
Q3 		$4.1M Sell
50,629
-19,869
-28% -$1.52M 1.33% 17
2017
Q2 		$4.99M Sell
70,498
-904
-1% -$60.2K 1.09% 20
2017
Q1 		$4.85M Buy
71,402
+2,407
+3% +$169K 1.03% 22
2016
Q4 		$4.88M Sell
68,995
-3,405
-5% -$253K 1.07% 23
2016
Q3 		$5.73M Sell
72,400
-11,111
-13% -$903K 1.47% 11
2016
Q2 		$6.97M Buy
83,511
+12,160
+17% +$1.08M 1.85% 9
2016
Q1 		$6.98M Hold
71,351
– – 2.18% 8
2015
Q4 		$7.22M Buy
71,351
+3,600
+5% +$375K 1.99% 9
2015
Q3 		$6.65M Sell
67,751
-1,273
-2% -$141K 1.97% 8
2015
Q2 		$8.08M Buy
69,024
+8,443
+14% +$923K 2.13% 6
2015
Q1 		$5.95M Buy
60,581
+485
+0.8% +$49.2K 1.63% 10
2014
Q4 		$5.67M Sell
60,096
-386
-0.6% -$39.9K 1.7% 8
2014
Q3 		$6.44M Sell
60,482
-4,544
-7% -$445K 1.92% 7
2014
Q2 		$5.39M Buy
65,026
+1,081
+2% +$84.1K 1.54% 9
2014
Q1 		$4.53M Buy
63,945
+155
+0.2% +$12.2K 2.49% 5
2013
Q4 		$4.79M Buy
+63,790
New +$4.44M 2.66% 4

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Perigon Wealth Management's GILD Position: Q1 2026 in Review

Perigon Wealth Management increased its Gilead Sciences (GILD) stake by 1.3% in Q1 2026, buying an estimated $68.2K and bringing the position to 38,551 shares worth $5.37M. The position accounts for 0.1% of the portfolio, ranked #205.

Perigon Wealth Management first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $8.08M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Perigon Wealth Management held 38,551 shares of Gilead Sciences worth $5.37M as of Q1 2026.
  • Perigon Wealth Management bought 487 Gilead Sciences shares in Q1 2026, an estimated $68.2K.
  • Gilead Sciences made up 0.1% of Perigon Wealth Management's portfolio in Q1 2026, its #205 holding.
  • Perigon Wealth Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Perigon Wealth Management's Gilead Sciences position peaked at $8.08M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.